Commonwealth Equity Services’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Commonwealth Equity Services’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$343K	Buy	11,451 +952	+9%	+$27K	﹤0.01%	3650
2026 Q1	$315K	Buy	10,499 +1,638	+18%	+$54.2K	﹤0.01%	3623
2025 Q4	$290K	Buy	8,861 +13	+0.1%	+$420	﹤0.01%	3681
2025 Q3	$306K	Buy	8,848 +466	+6%	+$14.9K	﹤0.01%	3619
2025 Q2	$235K	Sell	8,382 -2,978	-26%	-$79.8K	﹤0.01%	3805
2025 Q1	$285K	Buy	+11,360	New	+$287K	﹤0.01%	3546
2024 Q2	–	Sell	-6,500	Closed	-$209K	–	4094
2024 Q1	$209K	Hold	6,500	–	–	﹤0.01%	3585
2023 Q4	$264K	Buy	6,500 +500	+8%	+$18.4K	﹤0.01%	3279
2023 Q3	$207K	Buy	6,000 +500	+9%	+$19.5K	﹤0.01%	3353
2023 Q2	$224K	Buy	+5,500	New	+$224K	﹤0.01%	3304

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

denkapparat Operations Berlin, Germany $306M AUM 40.46% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

Commonwealth Equity Services's LKFT Position: Q2 2026 in Review

Commonwealth Equity Services increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 9.1% in Q2 2026, buying an estimated $27K and bringing the position to 11,451 shares worth $343K. The position accounts for ﹤0.01% of the portfolio, ranked #3650.

Commonwealth Equity Services first reported a position in LKFT in Q2 2023 and has held it in 10 quarters since. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

Commonwealth Equity Services held 11,451 shares of Lakefront Biotherapeutics American Depositary Shares worth $343K as of Q2 2026.
Commonwealth Equity Services bought 952 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $27K.
Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #3650 holding.
Commonwealth Equity Services first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2023 and has held it in 10 quarters since.
24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.